ANGO Latest Press Releases

-- October 29, 2026 --

AngioDynamics to Participate in Upcoming Investor Conferences Business Wire 8:00 AM

-- October 21, 2026 --

AngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IRE Business Wire 8:30 AM

-- October 14, 2026 --

AngioDynamics Announces Humana Medicare Advantage Coverage Policy Supporting Broader Access to NanoKnife IRE for Prostate and Liver Cancer Business Wire 7:00 AM

-- October 8, 2026 --

AngioDynamics Reports Fiscal Year 2027 First Quarter Financial Results; Continued Execution Drives Med Tech Growth and Profitability Business Wire 6:02 AM

AngioDynamics Announces Appointment of Eric Honroth as President and Chief Executive Officer Business Wire 6:00 AM

-- October 2, 2026 --

AngioDynamics and The PERT Consortium Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence Business Wire 6:00 AM

-- September 29, 2026 --

AngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026 Business Wire 8:07 AM

-- July 28, 2026 --

AngioDynamics to Participate in Upcoming Investor Conferences Business Wire 8:30 AM

-- July 14, 2026 --

AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability Business Wire 6:00 AM

-- June 30, 2026 --

AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026 Business Wire 8:00 AM

-- June 17, 2026 --

AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH) Business Wire 8:30 AM

Market Data Delayed 15 Minutes